Literature DB >> 16308870

Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: correlation with lipoblastoma morphology.

Petter Brandal1, Bodil Bjerkehagen, Sverre Heim.   

Abstract

Cytogenetics is of considerable value when diagnosing lipomatous tumours, as different tumour types have different more or less specific chromosomal abnormalities. One such entity is lipoblastoma, which is a benign lipomatous tumour that often exhibits rearrangements of chromosome bands 8q11-13, and the gene PLAG1 has been implicated as the target of these chromosomal changes. All lipomatous tumours karyotyped at the Norwegian Radium Hospital were reviewed, looking for rearrangements of 8q11-13. Five tumours exhibiting chromosomal abnormalities affecting this region were found. Only one of them was morphologically diagnosed as a lipoblastoma, two being classified as lipomas, one as a hibernoma, and one as a well-differentiated liposarcoma. The two tumours successfully analysed with bacterial artificial chromosomes (BACs) covering the gene PLAG1 showed involvement of this gene in the rearrangement. The findings raise the question as to what extent the diagnosis lipoblastoma should be based on histopathological or cytogenetic/molecular data or a combination thereof. When karyotypic information from this series was combined with available literature data, it was found that the sensitivity of 8q11-13 rearrangements for diagnosing lipoblastomas when found in a lipomatous tumour was 77% and that the corresponding specificity was 98%. The validity of these calculations of the diagnostic information provided by the cytogenetic findings is, of course, totally dependent on the morphological diagnosis made in each case. Regardless of what the precise phenotypic diagnosis was, it is suggested that lipomatous tumours with 8q11-13 rearrangement constitute a distinct pathogenetic entity. When selective therapies tailor-made against the specific pathogenetic rearrangement become available, it will become mandatory to pay more attention to the genetic constitution of the tumour cells than to their phenotypic appearance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16308870     DOI: 10.1002/path.1879

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Radiological-pathological correlation in lipoblastoma and lipoblastomatosis.

Authors:  Shruti Moholkar; Neil J Sebire; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2006-06-15

2.  Lipoblastoma: clinical features, treatment, and outcome.

Authors:  Kenneth Y Y Kok; P U Telisinghe
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  A novel t(3;8)(p13;q21.1) translocation in a case of lipoblastoma.

Authors:  Adam S Brinkman; Bradley Maxfield; Kara Gill; Neha J Patel; Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2012-04-10       Impact factor: 1.827

Review 4.  Contributions of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors.

Authors:  Jun Nishio
Journal:  J Biomed Biotechnol       Date:  2011-01-11

5.  Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.

Authors:  Javier A Arias-Stella; Ryma Benayed; Esther Oliva; Robert H Young; Lien N Hoang; Cheng-Han Lee; Achim A Jungbluth; Denise Frosina; Robert A Soslow; Cristina R Antonescu; Marc Ladanyi; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2019-03       Impact factor: 6.298

6.  A giant popliteal lipoblastoma in a 23-month-old girl: a case report.

Authors:  Shogo Hashimoto; Kazutaka Kikuta; Tetsuya Sekita; Robert Nakayama; Shinichiro Takayama; Aya Sasaki; Kaori Kameyama; Masaya Nakamura; Morio Matsumoto; Hideo Morioka
Journal:  J Med Case Rep       Date:  2017-12-05

7.  A case of unusual histology of infantile lipoblastoma confirmed by PLAG1 rearrangement.

Authors:  Toko Shinkai; Kouji Masumoto; Kentaro Ono; Eri Yano; Chie Kobayashi; Takashi Fukushima; Ryo Sumazaki; Kaishi Satomi; Masayuki Noguchi
Journal:  Surg Case Rep       Date:  2015-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.